MONJUVI
LIVE

Serial Number

88074194

Owner

MorphoSys AG

Attorney

Makiko Coffland

Filing Date

Aug 10, 2018

Add to watchlist:

No watchlists yet
View on USPTO

MONJUVI Trademark

Serial Number: 88074194 • Registration: 6031814

MONJUVI is a trademark filed by MorphoSys AG on August 10, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MorphoSys AG (48 trademarks)

Lena-Christ-Strasse 48
82152 Martinsried/Planegg , DE

Entity Type: 03

INCYTE HOLDINGS CORPORATION (2 trademarks)

WILMINGTON, DE 19803

Entity Type: 03

Trademark Details

Filing Date

August 10, 2018

Registration Date

April 14, 2020

Published for Opposition

July 16, 2019

Goods & Services

Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders

Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Filing History

TEAS SECTION 8 & 15 RECEIVED
Apr 10, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 14, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2024 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 1, 2024 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 24, 2024 ASCK
REGISTERED-PRINCIPAL REGISTER
Apr 14, 2020 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Mar 7, 2020 TMBN
OPPOSITION TERMINATED NO. 999999
Mar 7, 2020 OP.T
OPPOSITION DISMISSED NO. 999999
Mar 7, 2020 OP.D
OPPOSITION INSTITUTED NO. 999999
Jan 13, 2020 OP.I
POST PUBLICATION AMENDMENT - ENTERED
Nov 20, 2019 CHPB
ASSIGNED TO PETITION STAFF
Nov 18, 2019 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 22, 2019 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 22, 2019 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 31, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 4, 2018 GNRN
NON-FINAL ACTION E-MAILED
Dec 4, 2018 GNRT
NON-FINAL ACTION WRITTEN
Dec 4, 2018 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2018 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 20, 2018 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 15, 2018 PARI
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 18, 2018 AMPX
ASSIGNED TO LIE
Sep 18, 2018 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 9, 2018 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2018 NWOS
NEW APPLICATION ENTERED
Aug 14, 2018 NWAP